Day: March 10, 2025

Reykjavík Energy Green Finance Impact Report 2024

Written by Customer Service on March 10, 2025. Posted in Public Companies.

Reykjavík Energy (Orkuveita Reykjavíkur) has published the attached Reykjavík Energy Green Finance Impact Report 2024 – Audited, certified by the company’s independent auditors. The report is in English. The report is issued under the provisions of Reykjavík Energy’s Green Finance Framework, which was published on October 30, 2024, and received a “Dark Green” rating from the rating agency S&P Global. It details the allocation of green loan proceeds in 2024, totalling ISK 31.3 billion. “Since Reykjavík Energy took the lead in green financing in Iceland in 2019, the company has benefited from more favourable financing terms. Today, it is the most significant issuer of green bonds in Iceland. The reputation we have built will serve us well in the ambitious green projects ahead in energy production, utility operations,...

Purple Biotech Reports Fourth Quarter and Full-Year 2024 Financial Results

Written by Customer Service on March 10, 2025. Posted in Earnings Releases And Operating Results.

Completed successful clinical trials for CM24 and NT219 oncology assets, demonstrating clinical benefits and identifying potential biomarkers CM24 is well positioned for personalized treatment, with planned biomarker-driven Phase 2b study based on serum biomarkers CEACAM1 and myeloperoxidase NT219 headed into Phase 2 head and neck cancer study in combination with pembrolizumab (anti-PD1) and in combination with cetuximab (anti-EGFR) CAPTN-3 tri-specific platform yields promising preclinical data, supporting its differentiated benefit and well positioning it in the multi-specific/engagers antibody space REHOVOT, Israel, March 10, 2025 (GLOBE NEWSWIRE) — Purple Biotech Ltd. (“Purple Biotech” or “the Company”) (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class therapies that seek to overcome...

Dimensional Fund Advisors Ltd. : Form 8.3 – DALATA HOTEL GROUP PLC – Ordinary Shares

Written by Customer Service on March 10, 2025. Posted in Mergers And Acquisitions.

FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDERRULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVERRULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANTSECURITIES REPRESENTING 1% OR MORE1. KEY INFORMATION (a) Full name of discloser Dimensional Fund Advisors Ltd. in its capacity as investment advisor and on behalf its affiliates who are also investment advisors (”Dimensional”). Dimensional expressly disclaims beneficial ownership of the shares described in this form 8.3. (b) Owner or controller of interests and short positions disclosed, if different from 1(a)The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation to whose relevant securities this form relatesUse a separate...

Dimensional Fund Advisors Ltd. : Form 8.3 – SERICA ENERGY PLC – Ordinary Shares

Written by Customer Service on March 10, 2025. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)1. KEY INFORMATION (a) Full name of discloser: Dimensional Fund Advisors Ltd. in its capacity as investment advisor and on behalf its affiliates who are also investment advisors (”Dimensional”). Dimensional expressly disclaims beneficial ownership of the shares described in this form 8.3. (b) Owner or controller of interests and short positions disclosed, if different from 1(a):The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation to whose relevant securities this form relates:Use a separate form for each offeror/offeree Serica...

Dimensional Fund Advisors Ltd. : Form 8.3 – ENQUEST PLC – Ordinary Shares

Written by Customer Service on March 10, 2025. Posted in Mergers And Acquisitions.

A-Mark Continues Expansion into the Bullion Adjacent Collectible Coin Market by Acquiring Stack’s Bowers Galleries, AMS Holding, LLC, and Pinehurst Coin Exchange, Inc.

Written by Customer Service on March 10, 2025. Posted in Mergers And Acquisitions.

EL SEGUNDO, Calif., March 10, 2025 (GLOBE NEWSWIRE) — A-Mark Precious Metals, Inc. (NASDAQ: AMRK) (A-Mark or the Company), a leading fully integrated precious metals platform, announced its continued expansion into the collectible coin market with the following acquisitions:On February 28, 2025, A-Mark completed the previously reported acquisition of Spectrum Group International, Inc. (SGI), the parent of Stack’s Bowers Galleries (SBG), one of the world’s largest rare coin and currency auction houses and a leading wholesale and retail dealer specializing in numismatic and bullion products. SBG generated Total Revenue of $536.4 million and EBITDA of $10.9 million during the fiscal year ended June 30, 2024. On March 9, 2025, A-Mark entered into a definitive agreement to acquire the 90% of AMS Holding, LLC (AMS) not owned by A-Mark....

Avalon GloboCare and YOOV, a Leading Business AI Automation Solutions Provider, Enter into Merger Agreement

Written by Customer Service on March 10, 2025. Posted in Mergers And Acquisitions.

YOOV Achieves 59.1% Annual Revenue Growth, Reporting Unaudited Revenue of $45.7 Million with Net Income of $3.4 Million for Calendar Year 2024, Versus Unaudited Revenue of $28.7 Million with Net Loss of $2.4 Million for Calendar Year 2023 Upon Consummation of the Merger, Pending Nasdaq Approval, the New Combined Company is Expected to Trade Under the Nasdaq Symbol “YOOV” FREEHOLD, N.J., March 10, 2025 (GLOBE NEWSWIRE) — Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a commercial-stage company dedicated to developing and delivering precision diagnostic consumer products, announced today that it has entered into a definitive merger agreement with YOOV Group Holding Limited (“YOOV”), a leading provider of business artificial intelligence (“AI”) automation solutions. Under the agreement, YOOV will merge with and...

Serstech receives an order of 2.1 MSEK from its partner Kaiser

Written by Customer Service on March 10, 2025. Posted in Public Companies.

Serstech has today received an order from its partner Kaiser in Singapore. The order consists of SERS consumables. The value of the order is 2.1 MSEK, and it will be delivered and invoiced in Q2 2025. For further information, please contact: Stefan Sandor, CEO, Serstech AB Phone: +46 739 606 067 Email: ss@serstech.com or Thomas Pileby, Chairman of the Board, Serstech AB Phone: +46 702 072 643 Email: tp@serstech.com or visit: www.serstech.com This is information that Serstech AB (publ.) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above at 13:30 CET on March 10, 2025. Certified advisor to Serstech is Svensk Kapitalmarknadsgranskning AB (SKMG). About Serstech Serstech delivers solutions for chemical identification and...

Biodexa Announces Successful Outcome of a Type C Meeting with FDA Regarding the Phase 3 Program for eRapa in FAP

Written by Customer Service on March 10, 2025. Posted in Public Companies.

March 10, 2025 Biodexa Announces Successful Outcome of a Type C Meeting with FDA Regarding the Phase 3 Program for eRapa in FAP Clears the way to finalize Phase 3 protocol and recruit sites for U.S. Phase 3 substantially funded by $17.0 million CPRIT grant and $8.5 million Company match Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) (Nasdaq: BDRX), a clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of diseases with unmet medical needs, today announced the results of its Type C meeting with the U.S. Food and Drug Administration (“FDA”) regarding the protocol for the planned registrational Phase 3 study of eRapa in familial adenomatous polyposis (“FAP”). The Type C meeting followed a productive End of Phase 2 meeting with FDA and the publication of Phase 2 data of eRapa in...

Cohen & Company Reports Fourth Quarter & Full Year 2024 Financial Results

Written by Customer Service on March 10, 2025. Posted in Dividend Reports And Estimates.

Board Declares Quarterly Dividend of $0.25 per Share PHILADELPHIA and NEW YORK, March 10, 2025 (GLOBE NEWSWIRE) — Cohen & Company Inc. (NYSE American: COHN), a financial services firm specializing in an expanding range of capital markets and asset management services, today reported financial results for its fourth quarter and full year ended December 31, 2024. Summary Operating Results Three Months Ended Twelve Months Ended($ in thousands) 12/31/24 9/30/24 12/31/23 12/31/24 12/31/23 Net trading $ 8,947 $ 8,816 $ 7,809 $ 36,409 $ 30,926 Asset management 2,067 2,147 1,919 9,009 7,337 New issue and advisory 10,075 22,459 18,722 63,422 28,264 Principal transactions and other revenue (2,548 ) (1,727 ) 6,014 (29,242 ) 16,454 Total...

Day: March 10, 2025

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals